[M T]

A question for those MDs or medical researchers that might know: 

There was a finding of the one drug that might facilitate the infection by SARS-CoV-2.  How does that get handled? 

Does the FDA act on this (suggestive, but not sufficient) evidence or does it wait on further testing (human?)?
Does the FDA warn the manufacturers that the drug may lose its approval by some date, unless safety tests are done?
Does it become another paragraph in a 10,000 word insert?
How long might it take for the FDA to have enough evidence to warn users of the medication (assuming that the medication does facility infections of SARS-CoV-2)?

[M T]

A question for those MDs or medical researchers that might know: 

There was a finding of the one drug that might facilitate the infection by SARS-CoV-2.  How does that get handled? 

Does the FDA act on this (suggestive, but not sufficient) evidence or does it wait on further testing (human?)?
Does the FDA warn the manufacturers that the drug may lose its approval by some date, unless safety tests are done?
Does it become another paragraph in a 10,000 word insert?
How long might it take for the FDA to have enough evidence to warn users of the medication (assuming that the medication does facility infections of SARS-CoV-2)?